CanSino Biologics Inc
CanSino Biologics's GHG Emissions Data Preview
In 2023, CanSino Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, CanSino Biologics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into CanSino Biologics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of CanSino Biologics amounted to 37,294.91 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CanSino Biologics increased by 22.21%, suggesting that the company faced challenges in reducing its emissions from its core operations.
CanSino Biologics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CanSino Biologics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of CanSino Biologics were 3,541.18 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has CanSino Biologics reduced its Scope 1 emissions over time?
Since 2020, CanSino Biologics's Scope 1 emissions have decreased by 21.57%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), CanSino Biologics's Scope 1 emissions decreased by 41.37%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are CanSino Biologics's Scope 2 emissions?
In 2023, CanSino Biologics reported Scope 2 greenhouse gas (GHG) emissions of 33,753.73 tCOâ‚‚e without specifying the calculation method.
Has CanSino Biologics reduced its Scope 2 emissions over time?
Since 2020, CanSino Biologics's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 163.18%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), CanSino Biologics's Scope 2 emissions (Unspecified Calculation Method) rose by 37.9% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does CanSino Biologics use for Scope 2 reporting?
In 2023, CanSino Biologics reported its Scope 2 emissions using an unspecified methodology.
CanSino Biologics's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)